DifGen Pharmaceuticals Acquires the Operating and Manufacturing Assets of an FDA-Registered Finished Dosage Manufacturing Facility in Florida

DifGen Pharmaceuticals LLC (“DifGen”) announces that it has signed and closed an all-cash transaction through its subsidiary Aveva Drug Delivery Systems Inc. to purchase the operating and manufacturing assets of an FDA-registered manufacturing facility located in Tamarac, Florida. The facility has state-of the art manufacturing capability to handle solutions/ suspension/ emulsions through blow-fill-seal, form fill seal technology and traditional filling of liquid and semi-solid products in a variety of dosage forms including stick packs and unit-dose cups.

Read the full article: DifGen Pharmaceuticals Acquires the Operating and Manufacturing Assets of an FDA-Registered Finished Dosage Manufacturing Facility in Florida //

Source: https://www.prnewswire.com/news-releases/difgen-pharmaceuticals-acquires-the-operating-and-manufacturing-assets-of-an-fda-registered-finished-dosage-manufacturing-facility-in-florida-enhancing-its-manufacturing-footprint-in-the-united-states-with-the-addition-of-manufac-302091478.html

Leave a Comment

Your email address will not be published.

Scroll to Top